- Messages
- 1,613
- Type of diabetes
- Family member
- Treatment type
- I do not have diabetes
Blood glucose self-monitoring provides a snapshot of the blood glucose level. Depending on the measured value, patients can then take appropriate measures, for example, by eating something. However, blood glucose self-monitoring is not suitable for determining the quality of metabolic control. The HbA1c value is used for this. It is an indicator for long-term blood glucose control and serves as the "memory” for the blood glucose level. High HbA1c values in diabetes indicate poor metabolic control. /quote]
HbA1c is rightly as they say an indicator, shows a trend. For anybody to rely on that on it's own as a measure of control is sheer folly ! It does not show any peaks (Hyper's) or troughs (Hypo's), the true indicator of control is frequent daily testing.
Has any of these so called ' experts' ever thought that the reason for poor metabolic control is because many Diabetic's are denied the opportunty to test frequently to get good control by some
of the very same 'experts' who came up with this little bit of rubbish ! It is from Germany,
however the same thinking seems to be prevalent in some circles here too.
What a load of b............... :twisted:
Patch said:Telling a Type 2 Diabetic not to measure his/her BG is like telling an overweight person not to weigh themselves...
Ignorance is NOT bliss.
goji said:Totally agree! I was told by a nurse the other week not to measure my blood pressure at home as 'home testing can cause patients to get worried"!!! :twisted:
I can't stand that NHS mentality that thinks the HCP 'knows best' and the silly patient shouldn't worry their little head about things. It's only through testing that we can chart patterns, identify problems and get accurate treatments!
Administrator said:
cugila said:Here is a link to the full text of the article.
http://www.iqwig.de/index.991.en.html
A short extract:
Contrary to the widely-held belief, there is no proof that non-insulin-dependent patients with type 2 diabetes benefit from glucose self-monitoring. Moreover, it remains unclear whether an additional benefit is displayed by the blood test compared to the urine test or vice versa, in other words, whether one or other of the tests might offer an advantage to patients. The current data are quantitatively and qualitatively inadequate: the few trials that are suitable for investigating these questions have not included or have insufficiently reported many outcomes important to patients. Owing to their short duration, it is also not possible to draw any conclusions on the long-term benefit of glucose self-monitoring. This is the conclusion of the final report of the Institute for Quality and Efficiency in Health Care (IQWiG), published on 14 December 2009.